Cite Filings / AGMB / 0001104659-26-115567
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
6-K

Report of Foreign Issuer

AgomAb Therapeutics NV · Filed 2026-10-13 · Acc 0001104659-26-115567

Documents 1

  • 6-K Report of Foreign Issuer , tm2627540d1_6k.htm

Around this filing

  • 2026-10-13 6-K Report of Foreign Issuer
  • 2026-10-09 4 Director bought 5,000 shares at $8.90 ($44,500)
  • 2026-10-07 4 Chief Executive Officer bought 11,000 shares at an average $8.58 ($94,380)
  • 2026-10-07 4 Chief Financial Officer bought 10,000 shares at an average $8.59 ($85,940)
  • 2026-10-07 4 Director bought 10,000 shares at an average $8.64 ($86,350)
  • 2026-10-01 6-K Report of Foreign Issuer

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2627540d1_6k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…